214 related articles for article (PubMed ID: 1597134)
1. The effect of 22-oxacalcitriol on serum calcitriol.
Dusso AS; Negrea L; Finch J; Kamimura S; Lopez-Hilker S; Mori T; Nishii Y; Brown A; Slatopolsky E
Endocrinology; 1992 Jun; 130(6):3129-34. PubMed ID: 1597134
[TBL] [Abstract][Full Text] [Related]
2. Suppression of PTH and decreased action on bone are partially responsible for the low calcemic activity of 22-oxacalcitriol relative to 1,25-(OH)2D3.
Finch JL; Brown AJ; Mori T; Nishii Y; Slatopolsky E
J Bone Miner Res; 1992 Jul; 7(7):835-9. PubMed ID: 1642151
[TBL] [Abstract][Full Text] [Related]
3. The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine.
Brown AJ; Finch J; Grieff M; Ritter C; Kubodera N; Nishii Y; Slatopolsky E
Endocrinology; 1993 Sep; 133(3):1158-64. PubMed ID: 8396012
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of 19-nor-1,25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats.
Slatopolsky E; Cozzolino M; Finch JL
Kidney Int; 2002 Oct; 62(4):1277-84. PubMed ID: 12234297
[TBL] [Abstract][Full Text] [Related]
5. Calcemic response to parathyroid hormone in renal failure: role of phosphorus and its effect on calcitriol.
Rodriguez M; Martin-Malo A; Martinez ME; Torres A; Felsenfeld AJ; Llach F
Kidney Int; 1991 Dec; 40(6):1055-62. PubMed ID: 1762306
[TBL] [Abstract][Full Text] [Related]
6. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
7. Calcemic response to parathyroid hormone in renal failure: role of calcitriol and the effect of parathyroidectomy.
Rodriguez M; Felsenfeld AJ; Llach F
Kidney Int; 1991 Dec; 40(6):1063-8. PubMed ID: 1762307
[TBL] [Abstract][Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
9. 22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure.
Monier-Faugere MC; Geng Z; Friedler RM; Qi Q; Kubodera N; Slatopolsky E; Malluche HH
Kidney Int; 1999 Mar; 55(3):821-32. PubMed ID: 10027919
[TBL] [Abstract][Full Text] [Related]
10. Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism.
Slatopolsky E; Finch JL; Brown AJ; Ritter CS; Mizobuchi M; Plum LA; Clagett-Dame M; Sicinski RR; DeLuca HF
J Bone Miner Res; 2007 May; 22(5):686-94. PubMed ID: 17444814
[TBL] [Abstract][Full Text] [Related]
11. The interaction of PTH and dietary phosphorus and calcium on serum calcitriol levels in the rat with experimental renal failure.
Martin-Malo A; Rodriguez M; Martinez ME; Torres A; Felsenfeld AJ
Nephrol Dial Transplant; 1996 Aug; 11(8):1553-8. PubMed ID: 8856210
[TBL] [Abstract][Full Text] [Related]
12. The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.
Brown AJ; Ritter CR; Finch JL; Morrissey J; Martin KJ; Murayama E; Nishii Y; Slatopolsky E
J Clin Invest; 1989 Sep; 84(3):728-32. PubMed ID: 2760211
[TBL] [Abstract][Full Text] [Related]
13. On the mechanisms for the selective action of vitamin D analogs.
Dusso AS; Negrea L; Gunawardhana S; Lopez-Hilker S; Finch J; Mori T; Nishii Y; Slatopolsky E; Brown AJ
Endocrinology; 1991 Apr; 128(4):1687-92. PubMed ID: 2004595
[TBL] [Abstract][Full Text] [Related]
14. A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia.
Slatopolsky E; Finch J; Ritter C; Denda M; Morrissey J; Brown A; DeLuca H
Am J Kidney Dis; 1995 Nov; 26(5):852-60. PubMed ID: 7485144
[TBL] [Abstract][Full Text] [Related]
15. Effects of i.v. and oral 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in dogs with chronic renal failure.
Takahashi F; Furuichi T; Yorozu K; Kawata S; Kitamura H; Kubodera N; Slatopolsky E
Nephrol Dial Transplant; 2002; 17 Suppl 10():46-52. PubMed ID: 12386269
[TBL] [Abstract][Full Text] [Related]
16. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.
Portale AA; Booth BE; Halloran BP; Morris RC
J Clin Invest; 1984 Jun; 73(6):1580-9. PubMed ID: 6547151
[TBL] [Abstract][Full Text] [Related]
17. Effects of estrogen on daylong circulating calcium, phosphorus, 1,25-dihydroxyvitamin D, and parathyroid hormone in postmenopausal women.
Packer E; Holloway L; Newhall K; Kanwar G; Butterfield G; Marcus R
J Bone Miner Res; 1990 Aug; 5(8):877-84. PubMed ID: 2173358
[TBL] [Abstract][Full Text] [Related]
18. Potent suppression of the parathyroid glands by hydroxylated metabolites of dihydrotachysterol(2).
Fan SL; Schroeder NJ; Calverley MJ; Burrin JM; Makin HL; Cunningham J
Nephrol Dial Transplant; 2000 Dec; 15(12):1943-9. PubMed ID: 11096138
[TBL] [Abstract][Full Text] [Related]
19. Calcium and phosphorus deficiency in rats: effects on PTH and 1,25-dihydroxyvitamin D3.
Rader JI; Baylink DJ; Hughes MR; Safilian EF; Haussler MR
Am J Physiol; 1979 Feb; 236(2):E118-22. PubMed ID: 420284
[TBL] [Abstract][Full Text] [Related]
20. Submaximal suppression of parathyroid hormone ameliorates calcitriol-induced aortic calcification and remodeling and myocardial fibrosis in uremic rats.
Jung S; Querfeld U; Müller D; Rudolph B; Peters H; Krämer S
J Hypertens; 2012 Nov; 30(11):2182-91. PubMed ID: 22902873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
